Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study

Autor: Yahya Mohzari, Mushira Enani, Asma S. Albujaidya, Bandar Alosaimi, Nada M. Alkhani, Ahmed A. Alrashed, Mona A. Alanazi, Amal Ben-Akresh, Ahmad Alamer, Tahir Mehmood Khan, Syed Mohammed Basheeruddin Asdaq, Ivo Abraham, Malak Almutairi, Wafa Alfahad, Maram M. Alghalbi, Noara Alhusseini

Publikováno v: Journal of Infection and Public Health, Vol 14, Iss 6, Pp 726-733 (2021)
Journal of Infection and Public Health

Background The uncertainty about COVID-19 outcomes in angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. This study aimed to determine the effect of ACEI/ARB use in patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b701adff8142b4fd727d1c2a485984cc
http://www.sciencedirect.com/science/article/pii/S1876034121000691

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals: Retrospective Cohort Study

Autor: Asma S. Albujaidya, Mushira Enani, Yahya Mohzari, Syed Mohammed Basheeruddin Asdaq, Ahmad Alamer, Ahmed A. Alrashed, Bandar Alosaimi, Malak Almutairi, Mona A. Alanazi, Ivo Abraham, Tahir Mehmood Khan, Nada M. Alkhani, Wafa Alfahad, Noara Alhusseini, Amal Ben-Akresh, Maram M. Alghalbi

Background: The uncertainty about COVID-19 outcomes in angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. The aim of this study was to determine the effect of ACEI/ARB use

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::26bad80780b6e8224b783bb7f4a5cec8
https://doi.org/10.21203/rs.3.rs-113824/v1

Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence.

Autor: Mohzari YA; Department of Clinical Pharmacy, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia; King Saud Medical City, Riyadh, Saudi Arabia., Alamer A; Department of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA., Alattas M; Department of Clinical Pharmacy, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia., Alrashed AA; Department of Pharmaceutical Services, Main hospital, King Fahad Medical City, Riyadh, Saudi Arabia., Alshehab NA; Department of Pharmacy, Al-Ahsa Hospital, Al-Ahsa, Saudi Arabia., Alkhaldi TK; Department of Pharmaceutical Service, Main Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., Alamer AA; Department of Internal Medicine, King Faisal University, Al-Ahsa, Saudi Arabia; Department of Infectious Diseases, McMaster University, Hamilton, Ohio, Canada., Asdaq SMB; Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia., Aljefri D; Department of Pharmacy, King Abdulaziz Medical City, Jeddah, Saudi Arabia., Alajami HN; Pharmaceutical Care Department, King Saud Medical City, Riyadh, Saudi Arabia., Alsowaida YS; Department of Clinical Pharmacy, College of Pharmacy, Hail University, Hail, Saudi Arabia; Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA., Mathew M; Department of Clinical Pharmacy, King Saud Medical City, Riyadh, Saudi Arabia., AlMusawa MI; Division of Pharmaceutical Care, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia., Alomar M; Dammam Medical Complex, First Health Cluster in Eastern Province, Saudi Arabia., Alharbi RY; Department of Clinical Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia., Khuwaja M; Division of Pharmaceutical Care, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia., Bamogaddam RF; Department of Clinical Pharmacy, King Saud Medical City, Riyadh, Saudi Arabia., Alharthi AH; Department of Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia., Faqihi AY; Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., Alrumayyan BF; Department of Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., Alshareef A; Department of Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia., Alhassan BM; Department of Clinical Pharmacy, Almoosa Specialist Hospital, Al-Ahasa, Saudi Arabia., Damfu NY; Department of Pharmaceutical Care, King Abdulaziz Medical City, Jeddah, Saudi Arabia., Alajmi GS; Department of Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia., Albujaidy A; Department of Clinical Pharmacy Service, Prince Mohammed bin Abdulaziz Hospital, Riyadh, Saudi Arabia., Alghalbi M; Department of Pharmaceutical Services, Clinical Pharmacy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Alajlan SA; Department of Pediatric Dentistry, King Fahad Medical City, Riyadh, Saudi Arabia., Abraham I; Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA., Almulhim AS; Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.

Publikováno v: Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2022 Jul; Vol. 20 (7), pp. 1037-1047. Date of Electronic Publication: 2022 Mar 07.